IMPLEMENTATION OF QUALITY BY DESIGN (QBD) APPROACH IN FORMULATION AND DEVELOPMENT OF RITONAVIR PELLETS USING EXTRUSION SPHERONIZATION METHOD

SATISH K. MANDLIK; PAYAL P. AGARWAL; HARSHAL P. DANDGAVHAL

doi:10.22159/ijap.2020v12i1.35453

Authors

SATISH K. MANDLIK STES’s Sinhgad College of Pharmacy Vadgaon (Bk), SP Pune University, Pune, India
PAYAL P. AGARWAL STES’s Sinhgad College of Pharmacy Vadgaon (Bk), SP Pune University, Pune, India
HARSHAL P. DANDGAVHAL STES’s Sinhgad College of Pharmacy Vadgaon (Bk), SP Pune University, Pune, India

DOI:

https://doi.org/10.22159/ijap.2020v12i1.35453

Keywords:

Extrusion, Spheronization, Pellets, Quality by Design (QbD), Plackett-Burman Design, Optimization

Abstract

Objective: Ritonavir is an antiretroviral drug used for HIV-AIDS treatment. The purpose of this research work was to implement the quality by design (QbD) approach in formulation of ritonavir sustained-release pellets by industrially applied extrusion spheronization technique.

Methods: Pellets were prepared by extrusion spheronization method and evaluated for their physicochemical properties. Initially, on the basis of prior knowledge Quality Target Product Profile (QTTP) element was identified and further Critical Quality Attributes (CQA) elements were defined. Risk assessment (RA) was done by two tools as failure mode and effect analysis (FMEA) and fishbone diagram (Ishikawa plot). Placket Burman design was implemented as a screening design using seven high-risk factors (spheronization speed, spheronization time, extrusion speed, drying method, PVP K 30, cross povidone, and solvent). Optimization study was done by 2³full factorial design with three critical factors as (spheronization speed, extrusion speed and PVP K 30). The in vitro drug release was studied in both gastric and intestinal fluids for 12 h using USP Ι apparatus. Control space was established for the sustained release pellets.

Results: Among all batches obtained in 2³full factorial design, batch R7 was found to be effective with carr’s index value of 5.281, percentage yield of 69.6%, time required to release 50% drug was 8 h and percent drug release after 12 h was found 83.132 %, R7 batch was selected as optimized batch. Statistical analysis showed model terms were significant.

Conclusion: We can conclude that; sustained-release pellets of ritonavir were successfully designed using QbD approach.

Downloads

Download data is not yet available.

References

Sonar G, Rawat S. Optimization of pantoprazole enteric pellets coating process by qbd: effect of coating process variables on the intermediate quality of the product and scale-up. Int J Pharm Pharm Sci 2015;7:80-7.

Patil AS, Pethe AM. Quality by design (Qbd): a new concept for the development of quality pharmaceuticals. Int J Qual Assur 2013;4:13-9.

Gawade A, Chemate S, Kuchekar A. Pharmaceutical quality by design: a new approach in product development. Res Rev: J Pharm Pharm Sci 2013;2:1-8.

Roy S. Quality by design: a holistic concept of building quality in pharmaceuticals. Int J Pharm Biomed Res 2012;3:100-8.

Lawrence XY. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008;25:781-91.

Jain S. Quality by design (Qbd): a comprehensive understanding of implementation and challenges in pharmaceuticals development. Int J Pharm Pharm Sci 2014;6:29-35.

Wang J, Kan S, Chen T, Liu J. Application of quality by design (Qbd) to the formulation and processing of naproxen pellets by extrusion–spheronization. Pharm Dev Technol 2015;20:246-56.

Sirisha VR, Sri KY, Suresh K, Reddy Gk, Devanna N. A review of pellets and pelletization process-a multiparticulate drug delivery system. Int J Pharm Sci Res 2013;4:2145.

Kandukuri JM, Allenki V, Eaga Cm, Keshetty V, Jannu KK. Pelletization techniques for oral drug delivery. Int J Pharm Sci Res 2009;1:63-70.

Patil KJ, Sarode SM. Formulation and evaluation of sustained-release tablet of ritonavir. World J Pharm Pharm Sci 2014;3:854-69.

Kaljevic O, Djuris J, Djuric Z, Ibric S. Application of failure mode and effects analysis in quality by design approach for formulation of carvedilol compression coated tablets. J Drug Delivery Sci Technol 2016;32:56-63.

Us Food and Drug Administration. Quality By Design For Ands: An Example For Modified-Release Dosage Forms; 2011.

Sona PS, C Muthulingam, G Geetha. Preparation of pellets of bosentan by extrusion spheronizationscreening study of process parameters by plackett-burman design. Int J Pharm Life Sci 2012;2:88-97.

Dua S, Mahant S, Tiwari R. Influence of process and formulation variables on physical properties of the pellets using a 23 factorial design. Int J Pharm Sci Rev Res 2011;7:47-50.

Puranik PK, Khan FM. Formulation and evaluation of aceclofenac loaded sr matrix pellets: extrusion spheronization. Int J Pharm Pharm Sci 2013;5:781-9.

Upasani A, Kshirsagar S, Bhalekar M. Design and optimization of sustained release matrix tablet of opipramol hcl by using quality by design approach. Asian J Pharm Clin Res 2014;7:224-34.

Kumar KS, Bhowmik D, Srivastava S, Paswan S, Dutta As. Sustained-release drug delivery system potential. Pharma Innovation 2012;1:48-60.

Zameeruddin M, Namdev H, Jadhav SB, Kadam VS, Bharkad VB, Anil B. Recent advances of sustained-release oral drug delivery system: a review. Int J Pharm Sci Biomed Sci 2014;3:1479-89.

Lavanya K, Senthil V, Rathi V. Pelletization technology: a quick review. Int J Pharm Sci Res 2011;2:1337.

Jezerska L, Zajonc O, Vyletelek J, Zegzulka J. Mechanical material properties effect on pelletization. Wood Res 2016;61:307-20.

Singh G, Pai RS, Devi VK. Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function. J Young Pharm 2012;4:146-56.

S SY, V SS, N KR. Formulation optimization of promethazine theoclate immediate release pellets by using the extrusion-spheronization technique. Int J Appl Pharm 2018;10:30-5.

Desai S, J Disouza, K Musle, H Avinash. Solubility enhancement of ritonavir by hot melt extrusion. Int J Pharm Pharm Sci 2016;8:309-12.